| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |